Zobrazeno 1 - 10
of 460
pro vyhledávání: '"nucleos(t)ide analogue"'
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 6229-6238 (2024)
Guojun Shen,1,* Xueying Li,2,3,* Anqi Zheng,2 Mingxing Gong,4 Zhanhui Wang,2 Baolin Liao5 1Hepatology Unit, the Third People′s Hospital of Jiujiang City, Jiujiang, People’s Republic of China; 2Department of Infectious Diseases, Nanfang Ho
Externí odkaz:
https://doaj.org/article/4289a31a81444334b943b6a5c81a6f6d
Autor:
Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 4, Pp 577-589 (2024)
Background/Aims Four high-genetic barrier nucleos(t)ide analogues (NAs) for chronic hepatitis B (CHB), namely entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), and besifovir dipivoxil maleate (BSV), have been establis
Externí odkaz:
https://doaj.org/article/b6bcd490553b4811b0630e834a30a8f1
Autor:
Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101089- (2024)
Background & Aims: The association between hepatitis B envelope antigen (HBeAg) seroclearance during long-term nucleos(t)ide analogue (NA) treatment and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) remains unc
Externí odkaz:
https://doaj.org/article/fc34919f2cb14440bf605509859aac29
Autor:
Meng-Ju Lin, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Chi-Ling Chen, Jyh-Ming Liou, Tai-Chung Tseng, Chen-Hua Liu, Chun-Ming Hong, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 7, Pp 564-573 (2023)
Background/purpose: Distinct hepatitis relapse has been observed after discontinuing entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients. End-of-therapy (EOT) serum cytokines were compared and used for
Externí odkaz:
https://doaj.org/article/2d3aedfe41f741b3ab626b5406e1d37c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fangfang Sun, Zhenhua Li, Leiping Hu, Wen Deng, Tingting Jiang, Shiyu Wang, Xiaoyue Bi, Huihui Lu, Liu Yang, Yanjie Lin, Zhan Zeng, Ge Shen, Ruyu Liu, Min Chang, Shuling Wu, Yuanjiao Gao, Hongxiao Hao, Mengjiao Xu, Xiaoxue Chen, Lu Zhang, Yao Lu, Jianping Dong, Yao Xie, Minghui Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveTo investigate the sustained virological response and relapse in chronic hepatitis B (CHB) patients with hepatitis B e antigen (HBeAg) positive after stopping oral antiviral drugs, and to monitor the disease progression and the incidence of
Externí odkaz:
https://doaj.org/article/bd5cbe62afc8442a8f2288ad23211415
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Korean Journal of Gastroenterology, Vol 77, Iss 6, Pp 285-293 (2021)
Background/Aims: The HBsAg levels have been used to monitor the chronic hepatitis B (CHB) treatment response to antiviral therapy. On the other hand, it is unclear if the HBsAg quantification levels at each treatment point differ according to the HBe
Externí odkaz:
https://doaj.org/article/1b59d51321174ac89c8d0664eaea06d2
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 626-631 (2021)
Background: Limited data exist regarding the efficacy and long-term safety of nucleos(t)ide analogue therapy throughout pregnancy for women with chronic hepatitis B and their children. Methods: This retrospective cohort study included 165 women in to
Externí odkaz:
https://doaj.org/article/fbd8b40f79094b6ba77a573a3dcf24b9
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The impact of hepatic steatosis (HS) on treatment response following nucleos(t)ide analogue (NA) treatment for chronic hepatitis B (CHB) patients has not been clearly elucidated. We aimed to investigate the difference in HBeAg ser
Externí odkaz:
https://doaj.org/article/2adeae5e0cdb451f9bd5effd4c9b5b5a